90 related articles for article (PubMed ID: 27173147)
21. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control?
Al-Sanea N; Isbister WH
ANZ J Surg; 2004 Apr; 74(4):229-32. PubMed ID: 15043733
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
23. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer.
Ha YH; Jeong SY; Lim SB; Choi HS; Hong YS; Chang HJ; Kim DY; Jung KH; Park JG
Ann Surg; 2010 Aug; 252(2):336-40. PubMed ID: 20647928
[TBL] [Abstract][Full Text] [Related]
24. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.
Huh JW; Kim HR; Kim YJ
Dis Colon Rectum; 2013 Jun; 56(6):698-703. PubMed ID: 23652742
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of rectal cancer and follow up].
Charúa-Guindic L
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():126-31. PubMed ID: 18277500
[No Abstract] [Full Text] [Related]
26. [Effects of enterostomy in treating locally advanced rectal cancer with combined chemoradiotherapy and operation].
Liu Y; Li DC; Feng HY; Zhu Y; Liu LY
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):455-8. PubMed ID: 17686300
[TBL] [Abstract][Full Text] [Related]
27. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?
Mignanelli ED; de Campos-Lobato LF; Stocchi L; Lavery IC; Dietz DW
Dis Colon Rectum; 2010 Mar; 53(3):251-6. PubMed ID: 20173469
[TBL] [Abstract][Full Text] [Related]
28. Control of pelvic symptoms in patients with rectal cancer and synchronous metastases.
Tougeron D; Di Fiore F; Lefebure B; Hamidou H; Tuech JJ; Michot F; Paillot B; Michel P
Gastroenterol Clin Biol; 2009 Dec; 33(12):1106-13. PubMed ID: 19423254
[TBL] [Abstract][Full Text] [Related]
29. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
[TBL] [Abstract][Full Text] [Related]
30. Two-stage surgical treatment of unresectable obstructive rectal cancer with synchronous hepatic metastases.
Tsimogiannis KE; Pappas-Gogos GK; Nikas K; Stefanaki-Nikou S; Gossios K; Tsimoyiannis EC
Am Surg; 2007 Dec; 73(12):1218-23. PubMed ID: 18186375
[TBL] [Abstract][Full Text] [Related]
31. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
32. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
33. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
34. Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.
Fokas E; Conradi L; Weiss C; Sprenger T; Middel P; Rau T; Dellas K; Kitz J; Rödel F; Sauer R; Rüschoff J; Beissbarth T; Arnold D; Ghadimi BM; Rödel C; Liersch T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):992-9. PubMed ID: 24210078
[TBL] [Abstract][Full Text] [Related]
35. KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.
Kim SY; Shim EK; Yeo HY; Baek JY; Hong YS; Kim DY; Kim TW; Kim JH; Im SA; Jung KH; Chang HJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):201-7. PubMed ID: 22672749
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
[TBL] [Abstract][Full Text] [Related]
39. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
[TBL] [Abstract][Full Text] [Related]
40. Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.
Pucciarelli S; Gagliardi G; Maretto I; Lonardi S; Friso ML; Urso E; Toppan P; Nitti D
Ann Surg Oncol; 2009 Apr; 16(4):893-9. PubMed ID: 19189187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
